Evidence map›Paper›PMID 24561538›Full record

ArticleHeart rhythm2014

KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia.

Matthew M Kalscheur, Ravi Vaidyanathan, Kate M Orland, Sara Abozeid, Nicholas Fabry, Kathleen R Maginot, Craig T January, Jonathan C Makielski, Lee L Eckhardt

Open access · greenAbstract readCase Reports
In one paragraph

Article in Heart rhythm, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Beta-Adrenergic Activation of the Inward Rectifier KInternational journal of molecular sciences · 2024
    Article
  5. The network of cardiac KNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  6. Article
  7. Tetramisole is a new IPharmacology research & perspectives · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Characterization of Loss-Of-FunctionFrontiers in genetics · 2021
    Article
  16. Article
  17. Genetic Loss ofCirculation. Arrhythmia and electrophysiology · 2020
    Article
  18. Article
  19. Article
  20. Flecainide treats a novelHeartRhythm case reports · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Matthew M KalscheurCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin.
Ravi VaidyanathanCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin.
Kate M OrlandUniversity of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin.
Sara AbozeidCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin.
Nicholas FabryCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin.
Kathleen R MaginotUniversity of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin.
Craig T JanuaryCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin; University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin.
Jonathan C MakielskiCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin.
Lee L EckhardtCellular and Molecular Arrhythmia Research Program, University of Wisconsin-Madison, Wisonsin; University of Wisconsin-Madison Inherited Arrhythmia Clinic, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin. Electronic address: lle@medicine.wisc.edu.
University of Wisconsin–Madison · US

Funding

Training Program in Translational Cardiovascular Science (TPTCS)T32HL007936 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Lee Lochbaum Eckhardt, Gail A Robertson · 2001 to 2026
$11.6M
RYANODINE RECEPTORS, Ca2+-TRIGGERED ARRHYTHMIAS AND HCMP01HL094291 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MOSS, RICHARD L · 2009 to 2013
$9.7M
Institutional Clinical and Translational Science AwardKL2TR000428 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$6.2M
Olympus FV1000 Livecell Confocal SystemS10RR025644 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI KAMP, TIMOTHY J. · 2011 to 2011
$433k
NCATS NIH HHS KL2 TR000428NCRR NIH HHS S10 RR025644NHLBI NIH HHS P01 HL094291NHLBI NIH HHS T32 HL007936NHLBI NIH HHS T32HL07936
6 · The paper itself

Abstract

backgroundKCNJ2 mutations are associated with a variety of inherited arrhythmia syndromes including catecholaminergic polymorphic ventricular tachycardia 3.

objectiveTo characterize the detailed cellular mechanisms of the clinically recognized KCNJ2 mutation R67Q.

methodsKir2.1 current density was measured from COS-1 cells transiently transfected with wild-type human Kir-2.1 (WT-Kir2.1) and/or a heterozygous missense mutation in KCNJ2 (R67Q-Kir2.1) by using the whole-cell voltage clamp technique. Catecholamine activity was simulated with protein kinase A-stimulating cocktail exposure. Phosphorylation-deficient mutants, S425N-Kir2.1 and S425N-Kir2.1/R67Q-S425N-Kir2.1, were used in a separate set of experiments. HA- or Myc-Tag-WT-Kir2.1 and HA-Tag-R67Q-Kir2.1 were used for confocal imaging.

resultsA 33-year-old woman presented with a catecholaminergic polymorphic ventricular tachycardia-like clinical phenotype and was found to have KCNJ2 missense mutation R67Q. Treatment with nadolol and flecainide resulted in the complete suppression of arrhythmias and symptom resolution. Under baseline conditions, R67Q-Kir2.1 expressed alone did not produce inward rectifier current while cells coexpressing WT-Kir2.1 and R67Q-Kir2.1 demonstrated the rectification index (RI) similar to that of WT-Kir2.1. After PKA stimulation, R67Q-Kir2.1/WT-Kir2.1 failed to increase peak outward current density; WT-Kir2.1 increased by 46% (n = 5), while R67Q-Kir2.1/WT-Kir2.1 decreased by 6% (n = 6) (P = .002). Rectification properties in R67Q-Kir2.1/WT-Kir2.1 demonstrated sensitivity to calcium with a decreased RI in the high-calcium pipette solution (RI 20.3% ± 4.1%) than in the low-calcium pipette solution (RI 36.5% ± 5.7%) (P < .05). Immunostaining of WT-Kir2.1 and R67Q-Kir2.1 individually and together showed a normal membrane expression pattern and colocalization by using the Pearson correlation coefficient.

conclusionsR67Q-Kir2.1 is associated with an adrenergic-dependent clinical and cellular phenotype with rectification abnormality enhanced by increased calcium. These findings are a significant advancement of our knowledge and understanding of the phenotype-genotype relationship of arrhythmia syndromes related to KCNJ2 mutations.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseAdultCalciumDNADNA Mutational AnalysisFemaleHeterozygoteHumansPatch-Clamp TechniquesPolymorphic Catecholaminergic Ventricular TachycardiaPotassium Channels, Inwardly RectifyingTachycardia, VentricularCalciumDNAKir2.1 channelPotassium Channels, Inwardly RectifyingArrhythmia syndromeCPVT3Inherited arrhythmiaKCNJ2Kir2.1Potassium inward-rectifier channelVentricular arrhythmia

Identifiers

PMID24561538
PMCPMC4257478
OpenAlexW2086302584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.